Molecular Neuroscientist Dies

Stephen Heinemann, who along with his colleagues identified the genes encoding the major excitatory neurotransmitter receptors in the brain, has passed away at age 75.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

SALK INSTITUTE FOR BIOLOGICAL STUDIESNeuroscientist Stephen Heinemann, a long-time professor at the Salk Institute for Biological Studies of La Jolla, California, and former president of the Society for Neuroscience whose research focus was on the molecular underpinnings of neurotransmission, died last week (August 6) of complications of kidney failure. He was 75.

Among his research accomplishments, Heinemann identified the genes encoding the major excitatory neurotransmitter receptors in the brain and his work on glutamate receptors.

“Steve was a giant of twentieth century neuroscience,” Salk Institute President William Brody said in a statement. “His discoveries opened many avenues to better understand the function of the brain and for pursuing new therapies for neurological disorders.”

Born in Boston in 1939, Heinemann earned a bachelor’s degree from Caltech in 1962 and a PhD in biochemistry from Harvard University in 1967. He then completed postdoctoral research at MIT and the Stanford University School of Medicine before joining the Salk faculty in 1970, where he established the institute’s Molecular Neurobiology Laboratory. Heinemann was president of the Society for Neuroscience from 2005 to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies